Stocks look to stay positive as Novo pops on pill approval, gold nears $4,500 - London Business News | Londonlovesbusiness.com
Briefly

Stocks look to stay positive as Novo pops on pill approval, gold nears $4,500 - London Business News | Londonlovesbusiness.com
"Grinding up: Santa Claus is in town, or on Wall St, as the S&P 500 rose for a third day with a sea of green across the board. AI stocks did well with Nvidia up 1.5% and Oracle gaining more than 3%. The broad market finished up 0.64% to near its all-time high with bulls eyeing the 7,000 level. The Nasdaq rose 0.5% for the session while the Dow Jones advanced 0.5%."
"Gold posted yet another record high close to $4,500, while silver also advanced to the $70 level. It's been a remarkable year for the precious metals - gone from being much maligned as yield-less assets that do nothing into cornerstone assets for any portfolio. Gold led the rally but it's not done as well as silver, platinum or palladium. Central banks buy gold, not the others, so is it just industrial demand?"
US equity benchmarks advanced, with the S&P 500 up for a third day and closing near its all-time high as Nvidia and Oracle contributed gains. The Nasdaq and Dow each rose about 0.5%, and bulls targeted the 7,000 level on the S&P. European indices hit record highs, led by the Stoxx 600, while Novo Nordisk rallied after US approval of a GLP-1 pill. The FTSE 100 has gained roughly 10% in five months and may test 10,000. Precious metals surged—gold near $4,500 and silver around $70—while sterling strengthened past $1.35 following upwardly revised UK business investment figures.
[
|
]